References
- Carrasquillo KG, Stanley AM, Aponte-Carro JC, De Jesus P, Costantino HR, Bosques CJ, Griebenow K. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J Control Release 2001; 76: 199–208
- Diwan M, Park TG. Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres. Int J Pharm 2003; 252: 111–22
- Dogar V, Sokhey J, Kumar S, Sood DK, Tahlan AK. Interference of thiomersal in biologicals during protein estimation. Biologicals 2002; 30: 271–75
- Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Jiang Y, Nagai T. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release 2006; 112: 35–42
- Férir G, Kaptein S, Neyts J, De Clercq E. Antiviral treatment of chronic hepatitis B virus the infections: The past, the present and the future. Rev Med Virol 2008; 18: 19–34
- Heijckmann CA, Menheere PPCA, Sels JJE, Beuls EAM, Wolffenbuttel BHR. Clinical experience with Sandostatin LAR®in patients with acromegaly. Neth J Med 2001; 59: 286–91
- Jiang LX, Run HY, Yang SH, Qiu XM. The application of pharmacokinetics in new drug's research and development. J Pharm Pract 2006; 24(5): 260–63
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75
- Mitwally MF, Diamond MP, Ayres J, Khan I, Shamma FN, Fakih MH. Low-dose Lupron-Depot with GnRH antagonist rescue: A novel pituitary down-regulation protocol during controlled ovarian hyperstimulation (COH) for assisted reproductive technology (ART). Fertil Steril 2005; 84: 321–2
- Ogawa Y, Yamamoto M, Takada S, Okada H, Shimamoto T. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: Influence of molecular weight and copolymer ratio of polymer. Chem Pharm Bull (Tokyo) 1988; 36: 1502–7
- Ravivarapu HB, Burton K, DeLuca PP. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur J Pharm Biopharm 2000; 50(2)263–70
- Sánchez A, Tobío M, González L, Fabra A, Alonso MJ. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 2003; 18: 221–9
- Sun Y, Wang JC, Zhang X, Zhang ZJ, Zheng Y, Chen DW, Zhang Q. Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: In vitro and in vivo studies. J Control Release 2008; 129: 192–9
- Uzé G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol 2007; 316: 71–95
- Wang J, Chua KM, Wang CH. Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres. J Colloid Interface Sci 2004; 271: 92–101
- Xu AL, Yang F, Gao JP, Zhao YM, Wang L, Dong ML, inventors; Sun Yat-Sen University, Guangzhou. A method for preparation of Interferon-loaded biodegradable PLGA microspheres China patent 1660412A. 2005 Aug 31
- Zhang YM, Yang F, Yang YQ, Song FL, Xu AL. Recombinant interferon-alpha2b poly(lactic-co-glycolic acid) microspheres: Pharmacokinetics-pharmacodynamics study in primates following intramuscular administration. Acta Pharmacol Sin 2008; 29(11): 1370–5
- Zhou S, Deng X, He S, Li X, Jia W, Wei D, Zhang Z, Ma J. Study on biodegradable microspheres containing recombinant interferon-alpha-2a. J Pharm Pharmacol 2002; 54: 1287–92